XOMA Co. (NASDAQ:XOMAP – Get Free Report) saw a large drop in short interest in the month of April. As of April 30th, there was short interest totaling 122 shares, a drop of 92.2% from the April 15th total of 1,568 shares. Based on an average daily trading volume, of 7,126 shares, the short-interest ratio is presently 0.0 days.
XOMA Stock Down 0.5%
XOMAP stock opened at $25.26 on Tuesday. XOMA has a 12 month low of $25.14 and a 12 month high of $30.00. The firm’s 50-day moving average is $25.97 and its 200 day moving average is $26.29.
XOMA Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 15th. Shareholders of record on Thursday, April 2nd were issued a dividend of $0.5391 per share. This represents a $2.16 annualized dividend and a yield of 8.5%. The ex-dividend date was Thursday, April 2nd.
About XOMA
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
See Also
- Five stocks we like better than XOMA
- Sony’s $4 Billion Bet on Rock & Roll Royalties
- Ubiquiti’s Uptrend Can Continue, But Don’t Rush to Buy It
- TMC Forges a New EV Supply Chain at the Bottom of the Sea
- Sell in May and Go Away—Starting With These 3 Stocks
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
